特殊情况下的肺血栓栓塞症诊断和治疗——2018年《肺血栓栓塞症诊治与预防指南》解读
万钧, 翟振国 . 特殊情况下的肺血栓栓塞症诊断和治疗——2018年《肺血栓栓塞症诊治与预防指南》解读[J]. 诊断学理论与实践, 2019 , 18(1) : 34 -36 . DOI: 10.16150/j.1671-2870.2019.01.007
| [1] | 中华医学科会呼吸病学分会肺栓塞与肺血管学组, 中国医师协会呼吸医师分会肺栓塞与肺血管病工作委员会, 全国肺栓与肺血管病防治协作组. 肺血栓栓塞症诊治与预防指南[J]. 中华医学杂志, 2018, 98(14):1060-1086. |
| [2] | Steinberg BA, Peterson ED, Kim S, et al. Use and outcomes associated with bridging during anticoagulation interruptions in patients with atrial fibrillation: findings from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)[J]. Circulation, 2015, 131(5):488-494. |
| [3] | Le Gal G, Kercret G, Ben Yahmed K, et al. Diagnostic value of single complete compression ultrasonography in pregnant and postpartum women with suspected deep vein thrombosis: prospective study[J]. BMJ, 2012, 344:e2635. |
| [4] | Romualdi E, Dentali F, Rancan E, et al. Anticoagulant therapy for venous thromboembolism during pregnancy: a systematic review and a meta-analysis of the literature[J]. J Thromb Haemost, 2013, 11(2):270-281. |
| [5] | Douma RA, van Sluis GL, Kamphuisen PW, et al. Clinical decision rule and D-dimer have lower clinical utility to exclude pulmonary embolism in cancer patients. Explanations and potential ameliorations[J]. Thromb Haemost, 2010, 104(4):831-836. |
| [6] | Lee AYY, Kamphuisen PW, Meyer G, et al. Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer: A Randomized Clinical Trial[J]. JAMA, 2015, 314(7):677-686. |
| [7] | Akl EA, Vasireddi SR, Gunukula S, et al. Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer[J]. Cochrane Database Syst Rev, 2011,(6):CD006649. |
| [8] | Condliffe R, Elliot CA, Hughes RJ, et al. Management dilemmas in acute pulmonary embolism[J]. Thorax, 2014, 69(2):174-180. |
| [9] | Athappan G, Sengodan P, Chacko P, et al. Comparative efficacy of different modalities for treatment of right heart thrombi in transit: a pooled analysis[J]. Vasc Med, 2015, 20(2):131-138. |
| [10] | Douketis JD, Spyropoulos AC, Spencer FA, et al. Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines[J]. Chest, 2012, 141(2 Suppl):e326S-e350S. |
| [11] | Cuker A, Gimotty PA, Crowther MA, et al. Predictive value of the 4Ts scoring system for heparin-induced thrombocytopenia: a systematic review and meta-analysis[J]. Blood, 2012, 120(20):4160-4167. |
| [12] | Kelton JG, Arnold DM, Bates SM. Nonheparin anticoagulants for heparin-induced thrombocytopenia[J]. N Engl J Med, 2013, 368(8):737-744. |
| [13] | Kang M, Alahmadi M, Sawh S, et al. Fondaparinux for the treatment of suspected heparin-induced thrombocytopenia: a propensity score-matched study[J]. Blood, 2015, 125(6):924-929. |
/
| 〈 |
|
〉 |
